These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16369711)

  • 1. Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery.
    Shan YS; Sy ED; Wang ST; Lee JC; Lin PW
    World J Surg; 2006 Jan; 30(1):119-26. PubMed ID: 16369711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
    Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
    Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.
    Ferreira D; Grenouillet F; Blasco G; Samain E; Hénon T; Dussaucy A; Millon L; Mercier M; Pili-Floury S
    Intensive Care Med; 2015 Jun; 41(6):1077-88. PubMed ID: 25894623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
    Eggimann P; Francioli P; Bille J; Schneider R; Wu MM; Chapuis G; Chiolero R; Pannatier A; Schilling J; Geroulanos S; Glauser MP; Calandra T
    Crit Care Med; 1999 Jun; 27(6):1066-72. PubMed ID: 10397206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
    Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
    Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective analysis of fluconazole efficacy in Candida-colonized, non-neutropenic, surgical patients in long-term intensive care].
    Kappe R; Streitzig S; Böhrer H
    Dtsch Med Wochenschr; 2001 Aug; 126(33):905-8. PubMed ID: 11514925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study.
    Liao X; Qiu H; Li R; Guo F; Liu W; Kang M; Kang Y;
    J Crit Care; 2015 Aug; 30(4):862.e1-5. PubMed ID: 26002430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
    Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients.
    Takesue Y; Kakehashi M; Ohge H; Imamura Y; Murakami Y; Sasaki M; Morifuji M; Yokoyama Y; Kouyama M; Yokoyama T; Sueda T
    World J Surg; 2004 Jun; 28(6):625-30. PubMed ID: 15366757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations.
    Sandven P; Qvist H; Skovlund E; Giercksky KE;
    Crit Care Med; 2002 Mar; 30(3):541-7. PubMed ID: 11990912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.
    Swoboda SM; Merz WG; Lipsetta PA
    Surg Infect (Larchmt); 2003; 4(4):345-54. PubMed ID: 15012861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.
    Rocco TR; Reinert SE; Simms HH
    Arch Surg; 2000 Feb; 135(2):160-5. PubMed ID: 10668874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study.
    Micek ST; Arnold H; Juang P; Hampton N; McKenzie M; Scolarici M; Kollef M
    Clin Ther; 2014 Sep; 36(9):1226-32. PubMed ID: 25064625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
    Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid.
    Li WS; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2017 Jun; 50(3):370-376. PubMed ID: 26321461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibilities of Candida species isolated from urine culture.
    Toka Özer T; Durmaz S; Yula E
    J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.